BRCA2-dependent homologous recombination is required for repair of Arsenite-induced replication lesions in mammalian cells

Nucleic Acids Research

Volumn 37, Issue 15, 2009, Pages 5105-5113

  Ying, Songmin ^a,c   Myers, Katie ^a   Bottomley, Sarah ^a   Helleday, Thomas ^b   Bryant, Helen E ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; BRCA1 PROTEIN; BRCA2 PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CHEMICAL CARCINOGENESIS; CHINESE HAMSTER; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FEMALE; HOMOLOGOUS RECOMBINATION; MAMMAL CELL; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; SINGLE STRANDED DNA BREAK;

ANIMALS; ARSENITES; BRCA2 PROTEIN; CARCINOGENS; CELL LINE; CRICETINAE; CRICETULUS; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA REPLICATION; RECOMBINATION, GENETIC;

MAMMALIA;

EID: 69849110187     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp538     Document Type: Article

References (64)

1. Chen,C.J. et al. (1992) Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer, 66, 888-892.
2. Chiou,H.Y. et al. (1995) Incidence of internal cancers and ingested inorganic arsenic: A seven-year follow-up study in Taiwan. Cancer Res., 55, 1296-1300.
3. Liu,Y.T. and Chen,Z. (1996) A retrospective lung cancer mortality study of people exposed to insoluble arsenic and radon. Lung Cancer, 14(Suppl. 1), S137-S148.
4. Chen,C.J. and Wang,C.J. (1990) Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res., 50, 5470-5474.
5. Tsai,S.M., Wang,T.N. and Ko,Y.C. (1999) Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch. Environ. Health, 54, 186-193.
6. IARC (2004) Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum., 84, 1-477.
7. WHO (1996) WHO guidelines for drinking water quality. Health criteria and other supporting information, WHO, Vol. 2, Geneva, pp. 940-949.
8. Pott,W.A., Benjamin,S.A. and Yang,R.S. (2001) Pharmacokinetics, metabolism, and carcinogenicity of arsenic. Rev. Environ. Contam. Toxicol., 169, 165-214.
9. IARC (1980) IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 23, Some Metals and Metallic Compounds. World Health Organisation, Geneva.
10. Styblo,M. et al. (2002) The role of biomethylation in toxicity and carcinogenicity of arsenic: A research update. Environ. Health Perspect., 110(Suppl. 5), 767-771.
11. Konig,A. et al. (1997) Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood, 90 562-570.
12. Sanz,M.A. (2006) Treatment of acute promyelocytic leukemia. Hematol. Am. Soc. Hematol. Educ. Program., 1, 147-155.
13. Danaee,H. et al. (2004) Low dose exposure to sodium arsenite synergistically interacts with UV radiation to induce mutations and alter DNA repair in human cells. Mutagenesis, 19, 143-148.
14. Hartwig,A. et al. (2003) Modulation of DNA repair processes by arsenic and selenium compounds. Toxicology, 193, 161-169.
15. Walter,I. et al. (2007) Impact of arsenite and its methylated metabolites on PARP-1 activity, PARP-1 gene expression and poly(ADP-ribosyl)ation in cultured human cells. DNA Repair (Amst), 6, 61-70.
16. Bau,D.T. et al. (2002) Oxidative DNA adducts and DNA-protein cross-links are the major DNA lesions induced by arsenite. Environ. Health Perspect., 110(Suppl. 5), 753-756.
17. Kessel,M. et al. (2002) Arsenic induces oxidative DNA damage in mammalian cells. Mol. Cell Biochem., 234-235, 301-308.
18. Li,D. et al. (2001) Formamidopyrimidine-DNA glycosylase enhances arsenic-induced DNA strand breaks in PHA-stimulated and unstimulated human lymphocytes. Environ. Health Perspect., 109, 523-526.
19. Matsui,M. et al. (1999) The role of oxidative DNA damage in human arsenic carcinogenesis: Detection of 8-hydroxy-2 - deoxyguanosine in arsenic-related Bowen's disease. J. Invest. Dermatol., 113, 26-31.
20. Wang,T.S. et al. (2001) Arsenite induces oxidative DNA adducts and DNA-protein cross-links in mammalian cells. Free Radic. Biol. Med. 31, 321-330.
21. Sciandrello,G. et al. (2004) Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis 25, 413-417.
22. Zhao,C.Q. et al. (1997) Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl Acad. Sci. USA, 94, 10907-10912.
23. Simeonova,P.P. et al. (2000) Arsenic mediates cell proliferation and gene expression in the bladder epithelium: Association with activating protein-1 transactivation. Cancer Res., 60, 3445-3453.
24. Hamadeh,H.K. et al. (1999) Arsenic disrupts cellular levels of p53 and mdm2: A potential mechanism of carcinogenesis. Biochem. Biophys. Res. Commun., 263, 446-449.
25. Shen,S. et al. (2008) Attenuation of DNA damage-induced p53 expression by arsenic: A possible mechanism for arsenic co-carcinogenesis. Mol. Carcinog., 47, 508-518.
26. Jiang,X.H. et al. (2001) Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. Int. J. Cancer, 91, 173-179.
27. Filippova,M. and Duerksen-Hughes,P.J. (2003) Inorganic and dimethylated arsenic species induce cellular p53. Chem. Res. Toxicol., 16 423-431.
28. Fuller,L.F. and Painter,R.B. (1988) A Chinese hamster ovary cell line hypersensitive to ionizing radiation and deficient in repair replication. Mutat. Res., 193, 109-121.
29. Blunt,T. et al. (1995) Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell, 80, 813-823.
30. Thompson,L.H. et al. (1982) A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair, and an extraordinary baseline frequency of sister-chromatid exchange. Mutat. Res., 95, 427-440.
31. Tebbs,R.S. et al. (1995) Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc. Natl Acad. Sci. USA, 92, 6354-6358.
32. Tucker,J.D. et al. (1991) Cytogenetic characterization of the ionizing radiation-sensitive Chinese hamster mutant irs1. Mutat. Res. 254, 143-152.
33. Griffin,C.S. et al. (2000) Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat. Cell Biol., 2, 757-761.
34. Kraakman-van der Zwet,M. et al. (2002) Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol. Cell Biol., 22, 669-679.
35. Dong,J.T. and Luo,X.M. (1993) Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts. Mutat. Res., 302, 97-102.
36. Cedervall,B. et al. (1995) Methods for the quantification of DNA double-strand breaks determined from the distribution of DNA fragment sizes measured by pulsed-field gel electrophoresis. Radiat. Res., 143, 8-16.
37. van Gent,D.C., Hoeijmakers,J.H. and Kanaar,R. (2001) Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet., 2, 196-206.
38. Baumann,P., Benson,F.E. and West,S.C. (1996) Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell, 87, 757-766.
39. Haaf,T. et al. (1995) Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proc. Natl Acad. Sci. USA, 92, 2298-2302.
40. Essers,J. et al. (2002) Nuclear dynamics of RAD52 group homologous recombination proteins in response to DNA damage. EMBO J., 21 2030-2037.
41. Helleday,T., Arnaudeau,C. and Jenssen,D. (1998) A partial hprt gene duplication generated by non-homologous recombination in V79 Chinese hamster cells is eliminated by homologous recombination. J. Mol. Biol., 279, 687-694.
42. Boulton,S.J. (2006) Cellular functions of the BRCA tumour-suppressor proteins. Biochem. Soc. Trans., 34 (Pt 5), 633-645.
43. Avemann,K. et al. (1988) Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks. Mol. Cell Biol., 8, 3026-3034.
44. Ryan,A.J. et al. (1991) Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. Nucleic Acids Res., 19, 3295-3300.
45. Tsao,Y.P. et al. (1993) Interaction between replication forks and topoisomerase I-DNA cleavable complexes: Studies in a cell-free SV40 DNA replication system. Cancer Res., 53, 5908-5914.
46. Strumberg,D. et al. (2000) Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5′-phosphorylated DNA double-strand breaks by replication runoff. Mol. Cell. Biol., 20, 3977-3987.
47. Saleh-Gohari,N. et al. (2005) Spontaneous homologous recombination is induced by collapsed replication forks that are caused by endogenous DNA single-strand breaks. Mol. Cell. Biol., 25, 7158-7169.
48. Schwerdtle,T. et al. (2003) Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis, 24, 967-974.
49. Ikegami,S. et al. (1978) Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha. Nature, 275, 458-460.
50. Dianov,G.L. and Parsons,J.L. (2007) Co-ordination of DNA single strand break repair. DNA Repair of small base lesions in DNA - from molecular biology to phenotype. DNA repair (Amst.), 6, 454-460.
51. Wu,M.M. et al. (2001) Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. Environ. Health Perspect. 109, 1011-1017.
52. Yanez,L. et al. (2003) DNA damage in blood cells from children exposed to arsenic and lead in a mining area. Environ. Res., 93 231-240.
53. Ding,W. et al. (2009) Inhibition of PARP-1 by arsenite interferes with repair of oxidative DNA damage. J. Biol. Chem., 284, 6809-6817.
54. Ding,W., Hudson,L.G. and Liu,K.J. (2005) Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol. Cell. Biochem., 279, 105-112.
55. Lerda,D. (1994) Sister-chromatid exchange (SCE) among individuals chronically exposed to arsenic in drinking water. Mutat. Res., 312, 111-120.
56. Mahata,J. et al. (2003) Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat. Res., 534, 133-143.
57. Mateuca,R.A. et al. (2008) hOGG1(326), XRCC1(399) and XRCC3(241) polymorphisms influence micronucleus frequencies in human lymphocytes in vivo. Mutagenesis, 23, 35-41.
58. Banerjee,M. et al. (2008) DNA repair deficiency leads to susceptibility to develop arsenic-induced premalignant skin lesions. Int. J. Cancer, 123, 283-287.
59. Douer,D. and Tallman,M.S. (2005) Arsenic trioxide: New clinical experience with an old medication in hematologic malignancies. J. Clin. Oncol., 23, 2396-2410.
60. Gazitt,Y. and Akay,C. (2005) Arsenic trioxide: An anti cancer missile with multiple warheads. Hematology, 10, 205-213.
61. Bryant,H.E. et al. (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose)polymerase. Nature, 434, 913-917.
62. Thomas,H.D. et al. (2007) Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial. Mol. Cancer Ther., 6, 945-956.
63. Edwards,S.L. et al. (2008) Resistance to therapy caused by intragenic deletion in BRCA2. Nature, 451, 1111-1115.
64. Mahata,J. et al. (2004) Chromosomal aberrations in arsenic-exposed human populations: A review with special reference to a comprehensive study in West Bengal, India. Cytogenet Genome Res, 104, 359-364.